Service - NCT Nationales Centrum für Tumorerkrankungen Heidelberg

The NCT Heidelberg Trial Center supports clinical-oncological and epidemiological studies initiated by investigators of the German Cancer Research Center Heidelberg (DKFZ) and the Heidelberg University Hospital (UKHD). The NCT Heidelberg Trial Center takes over tasks of the trial sponsor and offers competent advice and extensive support for planning, execution and analysis of clinical-oncological studies in accordance with international standards. Qualified, experienced and continuously trained personnel provide services in the fields of project management and study coordination, biostatistics, data management and information technology.

Detailed information on the NCT Trial Center and its range of services is available under Research » NCT Trial Center.

Study Requests and Feasibility Assessment

Sponsors, CROs, research networks, etc., please send your study request directly to the appropriate study team, according to the e-mail contact list below. You will receive prompt feedback, once the feasibility of your study request has been assessed. This flowchart shows our standard workflow for study/feasibility requests.

Study Team	Contact Person for Study/Feasibility Requests
CUP (Carcinoma of Unknown Primary)	PD Dr. Tilmann Bochtler tilmann.bochtler@med.uni-heidelberg.de Prof. Dr. Alwin Krämer Alwin.Kraemer@med.uni-heidelberg.de
Cross-Entity/Basket a) Phase 1 Studies b) Phase 2 – 4 Studies	a) Prof. Dr. Guy Ungerechts guy.ungerechts@nct-heidelberg.de b) Prof. Dr. Richard Schlenk richard.schlenk@nct-heidelberg.de
Gastrointestinal Tumors a) Upper GI b) Colorectal c) Liver/Bile Ducts/Pancreas	a) Prof. Dr. Georg Martin Haag georgmartin.haag@med.uni-heidelberg.de b) PD Dr. med. Bruno Christian Köhler bruno.koehler@med.uni-heidelberg.de c) Prof. Dr. Dr. Christoph Springfeld christoph.springfeld@med.uni-heidelberg.de
Gynecological Tumors/Breast Cancer	Prof. Dr. Andreas Schneeweiss andreas.schneeweiss@med.uni-heidelberg.de
Hematological Neoplasms	Studienportal Innere Medizin V studienportal.med5@med.uni-heidelberg.de
Skin Tumors	Prof. Dr. Jessica Hassel jessica.hassel@med.uni-heidelberg.de
Head and Neck Tumors	Dr. Sebastian Dieter sebastian.dieter@med.uni-heidelberg.de
Neuroendocrine Tumors	PD Dr. Leonidas Apostolidis leonidas.apostolidis@med.uni-heidelberg.de
Brain/CNS Tumors	Dr. Antje Wick antje.wick@med.uni-heidelberg.de
Phase 1 Studies	Prof. Dr. Guy Ungerechts guy.ungerechts@nct-heidelberg.de
Prevention	Prof. Dr. Hermann Brenner h.brenner@dkfz.de
Radiooncology	Prof. Dr. Dr. Jürgen Debus studien.radonk@med.uni-heidelberg.de
Sarcoma	Prof. Dr. Gerlinde Egerer Gerlinde.Egerer@med.uni-heidelberg.de PD Dr. Leonidas Apostolidis leonidas.apostolidis@med.uni-heidelberg.de
Supportive Therapy	NCT Studienportal studienportal.nct@med.uni-heidelberg.de
Thoracic Tumors	Prof. Dr. Michael Thomas Studienkoordination-Onkologie.THOR@med.uni-heidelberg.de
Urogenital Tumors	Dr. Stefanie Zschäbitz stefanie.zschaebitz@med.uni-heidelberg.de

Head of NCT Trial Center

NCT Trial Center

Study Requests and Feasibility Assessment